Advanced Enzyme Technologies

Advanced Enzyme surges 12% as Nalanda India Equity Fund ups stake by 3%

Advanced Vital Enzymes Private Limited, the promoter of Advanced Enzyme Technologies, has offloaded 2.57 million equity shares at a price of Rs 270.04 per share

Advanced Enzyme extends rally, zooms 45% in 1 week after FPI hikes stake

Advanced Vital Enzymes Private Limited, the promoter of the company, had sold 3 million equity shares or 2.69 per cent stake at price of Rs 265 per share on the NSE on September 24

Advanced Enzyme Technologies soars 30% in 2 days after FPI picks 4% stake

On Thursday, Nalanda India Equity Fund bought 4.19 million equity shares, representing 3.75 per cent stake, in Advanced Enzyme for Rs 111 crore

Advanced Enzyme Tech freezes at 20% upper circuit; stock hits 52-week high

The company may benefit from an increase in healthcare spending in the US and India.

Advanced Enzyme zooms over 25% in one week as promoter increases stakes

The stock moved higher by 10% to Rs 2,195, extending its 16% rally in past four trading days on NSE.

Advanced Enzyme slips 10% on weak December quarter results

The stock slipped 11% to Rs 1,601 after the company reported 28% YoY decline in its profit at Rs 14 cr in Q3FY17

Advanced Enzyme to buy JC Biotech for Rs 50 crore

The Indian enzyme market stood at $105 million last year

Advanced Enzyme soars 100% over issue price

The stock hit an intra-day high of Rs 1,949, appreciated 118% compared to its issue price of Rs 896 per share.

Advanced Enzyme extends rally on fund buying

On Monday, Reliance Mutual Fund - Vision Fund acquired 200,000 shares at price of Rs 1,229.43 per share, the NSE data shows.

Advanced Enzyme Technologies lists at 35% premium

The stock listed at Rs 1,210 as against its issue price of Rs 896 per share on the NSE and BSE

IPO Review: Advantage Advanced Enzyme

Niche play with robust growth potential should translate to higher earnings trajectory